These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 9375678)

  • 1. Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability.
    Castillo GM; Ngo C; Cummings J; Wight TN; Snow AD
    J Neurochem; 1997 Dec; 69(6):2452-65. PubMed ID: 9375678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation.
    Castillo GM; Cummings JA; Yang W; Judge ME; Sheardown MJ; Rimvall K; Hansen JB; Snow AD
    Diabetes; 1998 Apr; 47(4):612-20. PubMed ID: 9568695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease.
    Snow AD; Kinsella MG; Parks E; Sekiguchi RT; Miller JD; Kimata K; Wight TN
    Arch Biochem Biophys; 1995 Jun; 320(1):84-95. PubMed ID: 7793988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sulfate moieties of glycosaminoglycans are critical for the enhancement of beta-amyloid protein fibril formation.
    Castillo GM; Lukito W; Wight TN; Snow AD
    J Neurochem; 1999 Apr; 72(4):1681-7. PubMed ID: 10098877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abeta(1-40) prevents heparanase-catalyzed degradation of heparan sulfate glycosaminoglycans and proteoglycans in vitro. A role for heparan sulfate proteoglycan turnover in Alzheimer's disease.
    Bame KJ; Danda J; Hassall A; Tumova S
    J Biol Chem; 1997 Jul; 272(27):17005-11. PubMed ID: 9202014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of vascular heparan sulfate proteoglycan to Alzheimer's amyloid precursor protein is mediated in part by the N-terminal region of A4 peptide.
    Buée L; Ding W; Anderson JP; Narindrasorasak S; Kisilevsky R; Boyle NJ; Robakis NK; Delacourte A; Greenberg B; Fillit HM
    Brain Res; 1993 Nov; 627(2):199-204. PubMed ID: 8298962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel purification and detailed characterization of perlecan isolated from the Engelbreth-Holm-Swarm tumor for use in an animal model of fibrillar A beta amyloid persistence in brain.
    Castillo GM; Cummings JA; Ngo C; Yang W; Snow AD
    J Biochem; 1996 Aug; 120(2):433-44. PubMed ID: 8889831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteoglycan-mediated inhibition of A beta proteolysis. A potential cause of senile plaque accumulation.
    Gupta-Bansal R; Frederickson RC; Brunden KR
    J Biol Chem; 1995 Aug; 270(31):18666-71. PubMed ID: 7629198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain.
    Snow AD; Sekiguchi R; Nochlin D; Fraser P; Kimata K; Mizutani A; Arai M; Schreier WA; Morgan DG
    Neuron; 1994 Jan; 12(1):219-34. PubMed ID: 8292358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chondroitin sulfate perlecan enhances collagen fibril formation. Implications for perlecan chondrodysplasias.
    Kvist AJ; Johnson AE; Mörgelin M; Gustafsson E; Bengtsson E; Lindblom K; Aszódi A; Fässler R; Sasaki T; Timpl R; Aspberg A
    J Biol Chem; 2006 Nov; 281(44):33127-39. PubMed ID: 16956876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
    Vischer P; Feitsma K; Schön P; Völker W
    Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A beta and perlecan in rat brain: glial activation, gradual clearance and limited neurotoxicity.
    Holcomb LA; Gordon MN; Benkovic SA; Morgan DG
    Mech Ageing Dev; 2000 Jan; 112(2):135-52. PubMed ID: 10690926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An interaction between basement membrane and Alzheimer amyloid precursor proteins suggests a role in the pathogenesis of Alzheimer's disease.
    Narindrasorasak S; Altman RA; Gonzalez-DeWhitt P; Greenberg BD; Kisilevsky R
    Lab Invest; 1995 Mar; 72(3):272-82. PubMed ID: 7898047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain.
    Snow AD; Sekiguchi RT; Nochlin D; Kalaria RN; Kimata K
    Am J Pathol; 1994 Feb; 144(2):337-47. PubMed ID: 8311117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel glycosaminoglycan precursors as anti-amyloid agents part II.
    Kisilevsky R; Szarek WA
    J Mol Neurosci; 2002; 19(1-2):45-50. PubMed ID: 12212792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains.
    van Horssen J; Otte-Höller I; David G; Maat-Schieman ML; van den Heuvel LP; Wesseling P; de Waal RM; Verbeek MM
    Acta Neuropathol; 2001 Dec; 102(6):604-14. PubMed ID: 11761721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth.
    McLaurin J; Franklin T; Zhang X; Deng J; Fraser PE
    Eur J Biochem; 1999 Dec; 266(3):1101-10. PubMed ID: 10583407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laminin inhibition of beta-amyloid protein (Abeta) fibrillogenesis and identification of an Abeta binding site localized to the globular domain repeats on the laminin a chain.
    Castillo GM; Lukito W; Peskind E; Raskind M; Kirschner DA; Yee AG; Snow AD
    J Neurosci Res; 2000 Nov; 62(3):451-62. PubMed ID: 11054814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of perlecan (or a perlecan-related macromolecule) to isolated microglia in vitro and to microglia/macrophages following infusion of beta-amyloid protein into rodent hippocampus.
    Miller JD; Cummings J; Maresh GA; Walker DG; Castillo GM; Ngo C; Kimata K; Kinsella MG; Wight TN; Snow AD
    Glia; 1997 Oct; 21(2):228-43. PubMed ID: 9336237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and quantitation of perlecan mRNA levels in Alzheimer's disease and normal aged hippocampus by competitive reverse transcription-polymerase chain reaction.
    Maresh GA; Erezyilmaz D; Murry CE; Nochlin D; Snow AD
    J Neurochem; 1996 Sep; 67(3):1132-44. PubMed ID: 8752120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.